Track topics on Twitter Track topics that are important to you
Two separate analyses point to difficulties biosimilar manufacturers have had in carving out market share of branded drugs.
Original Article: Biosimilars Struggle to Gain Market Share in the U.S., Analysis ShowsNEXT ARTICLE
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...